Etoricoxib versus placebo for knee osteoarthritis
Fourteen days of etoricoxib 60 mg improves pain, hyperalgesia and physical function in individuals with knee osteoarthritis: a randomized controlled trialOsteoarthritis Cartilage. 2017 Nov;25(11):1781-1791
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
86 patients with symptomatic knee osteoarthritis were randomized to etoricoxib 60mg daily for 14 days or placebo for 14 days. Patients were assessed for outcome related to resting and dynamic pain, stiffness, function, and pressure pain threshold after 4 and 14 days of treatment. Results demonstrated significantly greater improvement after 14 days in the etoricoxib group compared to the placebo gr...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue